Latest Tumors Stories
Connie K. Ho for redOrbit.com – Your Universe Online Researchers from the Fox Chase Cancer Center recently discovered a novel method of improving cancer drugs, where they could block a specific pathway in the cell and provide an easier way for drugs to eliminate tumors. According to the American Cancer Society, cancer occurs when there is uncontrolled growth and expansion of abnormal cells. It is caused by external factors (such as chemicals, infectious organisms, radiation, and...
Study shows drug can shrink tumors and save kidneys Thousands of individuals have had kidneys removed unnecessarily because doctors misdiagnosed their disease. A new, international study published in The Lancet indicates that approximately one of every five individuals with kidney tumors common in patients with tuberous sclerosis complex (TSC), a genetic disorder, has had a kidney removed. Moreover, 40 percent had some kind of surgical procedure performed. Proper diagnosis could have...
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors. Reporting in the Jan. 9, 2013, edition of the on-line journal, PLOS ONE, the researchers describe a process of exploiting sickle-shaped red blood cells to selectively target oxygen deprived cancer tumors in mice and...
Cancer Treatment Centers of America(®) at Midwestern Regional Medical Center is the first cancer hospital in Illinois to perform a NanoKnife(®) Procedure CHICAGO, Jan. 7, 2013 /PRNewswire-USNewswire/ -- Interventional radiologists at Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) performed the first Nanoknife procedure in Illinois, using electricity to target hard to access tumors. The technology, called...
Immediate feedback shows if chemotherapy worked, or if additional treatment is needed Using two successive pairs of specialized CT scans, a team of Johns Hopkins and Dutch radiologists has produced real-time images of liver tumors dying from direct injection of anticancer drugs into the tumors and their surrounding blood vessels. Within a minute, the images showed whether the targeted chemotherapy did or did not choke off the tumors' blood supply and saved patients a month of worry about...
RIO DE JANEIRO, December 18, 2012 /PRNewswire/ -- An advanced radiotherapy treatment system, fully equipped for treating cancer with advanced, image-guided radiotherapy and radiosurgery, has been ordered by Clínicas Oncológicas Integradas (GRUPO COI) for installation at the group's Botafogo site in Rio de Janeiro. The TrueBeam(TM) system, which was designed to treat tumors with great accuracy and speed, is the first to be ordered by a treatment center in South America, and is...
CINCINNATI, Dec. 10, 2012 /PRNewswire-USNewswire/ -- Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder Neurofibromatosis 1 (NF1). (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Scientists from Cincinnati Children's Hospital Medical Center report their findings online Dec. 10 in the Journal of Clinical Investigation. "We can for the...
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) and US Oncology Research. The study is published by the journal Molecular Cancer Therapeutics and is currently available online. By sequencing, or spelling out, the billions...
PKM2 slips into nucleus to promote cancer; potential biomarker and drug approach discovered Researchers at The University of Texas MD Anderson Cancer Center have tracked down a cancer-promoting protein's pathway into the cell nucleus and discovered how, once there, it fires up a glucose metabolism pathway on which brain tumors thrive. They also found a vital spot along the protein's journey that can be attacked with a type of drug not yet deployed against glioblastoma multiforme, the...
-People with a type of brain tumor called glioblastoma live 12 months on average, so new forms of treatment for this malignancy are badly needed. -Viruses designed to kill cancer cells offer a safe way to treat these tumors, but the therapy doesn't work as well as expected. -This study found that a patient's immune system tries to eliminate the anticancer virus and blocking this immune activity gave the virus more time to kill cancer cells. Doctors now use cancer-killing viruses to treat...
